This Week In Diagnostics
Written on May 21, 2012
Blood test for bowel cancer
A team of Australian scientists report that they identified new genes that show identifiable changes in the blood of people with bowel cancer. The discovery, they say, could have the potential to underpin a new blood test that would signal the early stages of bowel cancer.
The...
This Week in Diagnostics
Written on May 7, 2012
QIAGEN participates in Grand Challenge Dx initiative
QIAGEN N.V. (NASDAQ: QGEN) says that it has joined the Point-of-Care Diagnostics (POC Dx) Initiative, led by the Bill & Melinda Gates Foundation and Grand Challenges Canada. The POC Dx Initiative is a research and development program with the goal of...
This Week In Diagnostics
Written on Apr 30, 2012
Horizon Discovery and H3 Biomedicine collaborate on personalized medicines
Horizon Discovery and H3 Biomedicine say they have entered into a collaboration agreement to identify and validate a panel of novel cancer drug targets. They plan to perform target-validation experiments identifying critical cancer...
Apricus Bio VP: Drug Delivery Space Is Evolving During Personalized Medicine Surge
Written on Apr 27, 2012
Apricus Bio [NASDAQ: APRI] has made some intriguing noise recently. The San Diego-based drug delivery company is actualizing its efforts abroad, receiving patent protection of its technology in Europe, exploring international partnerships for late-stage candidates and securing a Canadian distribution license...
Dr. Shi of EdgeTech Law: Genome Sequencing Could Soon Enter Mainstream
Written on Apr 24, 2012
In Part III of our interview with Dr. Qin Shi of Edgetech Law we visit the concept of human genome sequencing as a mainstream commodity. Dr. Shi is optimistic that genome sequencing can become an affordable and intriguing choice for patients and curious individuals, however she identifies the potential...
This Week In Diagnostics
Written on Apr 23, 2012
Report says automation drives European molecular Dx markets
New analysis from Frost & Sullivan has found that technology advances combined with the decreasing cost of automated systems is fuelling the growth of molecular diagnostics. According to the report, European Molecular Diagnostics Market, which...
